Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
08/12/2003 | US6605753 Transgenic mouse with increased insulin sensitivity; resistance to weight gain when fed a high fat, high carbohydrate diet |
08/12/2003 | US6605712 Isolated DNA comprising a radiation inducible promoter linked to a region encoding a polypeptide; use for regulating polypeptide expression and inhibiting tumor growth; anticarcinogenic agent |
08/12/2003 | US6605710 Gene whose expression promotes differentiation of myeloid progenitor cells into neutrophils and/or monocytes/macrophages |
08/12/2003 | US6605701 Insecticidal protein against the Western corn rootworm |
08/12/2003 | US6605592 Protein HOFNF53 |
08/12/2003 | US6605469 Vector ligated to regulatory sequence for gene expression |
08/12/2003 | US6605467 Fusion protein comprising the whole or part of the PP65 protein of human CMV, useable in particular for preparing a vaccine |
08/12/2003 | US6605466 Glycated collagen and fibroblasts |
08/12/2003 | US6605464 Expressible polynucleotides encoding eukaryotic heat shock proteins |
08/12/2003 | US6605458 Subtilase enzyme with insertion in active loop; wash detergents |
08/12/2003 | US6605457 Influenza vaccine |
08/12/2003 | US6605456 Nucleic acids encoding IKR-2, a protein kinase related to the I kappa B kinases |
08/12/2003 | US6605454 Microfluidic devices with monolithic microwave integrated circuits |
08/12/2003 | US6605449 Saturation mutagenesis to produce progenitor polynucleotide library |
08/12/2003 | US6605443 Drug screening for compound which disrupts Smad7 transforming growth-beta factor superfamily signal transduction inhibitory activity |
08/12/2003 | US6605433 Mitochondrial dosimeter |
08/12/2003 | US6605430 Genetic engineering to produce library of polynucleotides encoding polypeptides; screening, recovering |
08/12/2003 | US6605282 Inducing immune response against feline immunodeficiency virus; obtain animal, administer protective agent, detect immunological response against viral infection |
08/12/2003 | US6605280 Interleukin-18 binding proteins, their preparation and use for blocking the activity of IL-18 |
08/12/2003 | US6605275 Growing in vitro human neonatal or fetal hematopoietic stem cells from umbilical cord or placental blood collected at birth, introducing into human patient effective amount of progeny stem cells for hematopoietic reconstitution |
08/12/2003 | US6605271 Activating cell proliferation and differentiation in hematopoietic cells; obtain cells, incubate with modulator, monitor cell propagation |
08/12/2003 | CA2348132C A system for cell-based screening |
08/12/2003 | CA2264441C Methods for determining the biocompability of lipophilic substances in cell culture tests using nanoemulsions |
08/12/2003 | CA2248653C Vaccines for treatment of lymphoma and leukemia |
08/12/2003 | CA2223155C Secretion leader trap cloning method |
08/07/2003 | WO2003065042A1 Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
08/07/2003 | WO2003065004A2 Enzyme activation protease assay |
08/07/2003 | WO2003064666A1 Adenoviral vectors for modulating the cellular activities associated with pods |
08/07/2003 | WO2003064665A2 Viral vector |
08/07/2003 | WO2003064649A1 Promoter expressing foreign gene in root and shoot apex |
08/07/2003 | WO2003064645A1 Novel n-acetylgalactosamine transferase and nucleic acid encoding the same |
08/07/2003 | WO2003064637A1 Method and system for myocardial infarction repair |
08/07/2003 | WO2003064636A1 Separation, preparation and use of medullary hematopoietic stem cell |
08/07/2003 | WO2003064635A1 Method of constructing spheroids, spheroids and spheroid-contianing compositions |
08/07/2003 | WO2003064634A1 Liquid for frozen storage of primate embryo stem cells and frozen storage method |
08/07/2003 | WO2003064633A1 Method and system for fusion and activation following nuclear transfer in reconstructed embryos |
08/07/2003 | WO2003064632A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
08/07/2003 | WO2003064630A2 Cell culture medium |
08/07/2003 | WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
08/07/2003 | WO2003064622A2 Aggrecanase molecules |
08/07/2003 | WO2003064621A2 HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES |
08/07/2003 | WO2003064613A2 Amidases, nucleic acids encoding them and methods for making and using them |
08/07/2003 | WO2003064606A2 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
08/07/2003 | WO2003064601A2 Adult human olfactory stem cell |
08/07/2003 | WO2003064598A2 Serum-free media for chondrocytes and methods of use thereof |
08/07/2003 | WO2003064596A2 Desaturase genes, enzymes encoded thereby, and uses thereof |
08/07/2003 | WO2003064586A2 Method and device for cultivating cells in high densities and for obtaining products from said cells |
08/07/2003 | WO2003064496A2 Biodegradable polymer |
08/07/2003 | WO2003064474A1 Production of hybridoma producing antihuman cenp-a peptide monoclonal antibody and method of using the same |
08/07/2003 | WO2003064471A2 Gene for peripheral arterial occlusive disease |
08/07/2003 | WO2003064468A2 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof |
08/07/2003 | WO2003064467A1 A complex of a human foxc2 protein and a foxc2-interacting protein |
08/07/2003 | WO2003064463A2 Pluripotency determining factors and uses thereof |
08/07/2003 | WO2003063893A2 Fgfr agonists |
08/07/2003 | WO2003063802A2 Mixed haptenized tumor cells and extracts and methods of treating or screening for cancer |
08/07/2003 | WO2003063801A2 Treatment of tumor cells for use in immunotherapy of cancer |
08/07/2003 | WO2003063792A2 Compositions and methods related to tim-3, a th1-specific cell surface molecule |
08/07/2003 | WO2003063783A2 Multiple virus replicon culture systems |
08/07/2003 | WO2003063767A2 Rsv proteins, antibodies, compositions, methods and uses |
08/07/2003 | WO2003063766A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
08/07/2003 | WO2003063581A2 Compositions and methods for increasing animal size and growth rate |
08/07/2003 | WO2003063575A2 Endothelialization of vascular surfaces |
08/07/2003 | WO2003054199A3 Phytases and method for producing these phytases |
08/07/2003 | WO2003052091A8 Growth factor modified protein matrices for tissue engineering |
08/07/2003 | WO2003048375B1 Hybrid glycosylated products and their production and use |
08/07/2003 | WO2003046132A3 Antisense modulation of myd88 expression |
08/07/2003 | WO2003042366A3 A novel saitohin gene and uses of same |
08/07/2003 | WO2003040340A9 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer |
08/07/2003 | WO2003035834A3 Compositions and methods for making mutations in cell lines and animals |
08/07/2003 | WO2003024473A3 Retinoid receptor pan-antagonists for stimulating chondrogenesis |
08/07/2003 | WO2003020916A8 Spider silk protein encoding nucleic acids, polypeptides, antibodies and method of use thereof |
08/07/2003 | WO2003018788B1 Improved nitroreductase enzymes |
08/07/2003 | WO2003016516A3 Kinase crystal structures and materials and methods for kinase activation |
08/07/2003 | WO2002092825B1 Retroviral vectors for gene therapy |
08/07/2003 | WO2002088334A9 Chimeric immunoreceptor useful in treating human cancers |
08/07/2003 | WO2002077179A3 Leinamycin biosynthesis gene cluster and its components and their uses |
08/07/2003 | WO2002068615A3 Activation of lymphocyte populations expressing nkg2d using anti-nkg2d antibodies and ligand derivatives |
08/07/2003 | WO2002057457A3 Human proteins 55562 and 21617, and methods of use thereof |
08/07/2003 | WO2002052023A3 Position-independent and tissue specific expression of a transgene in milk of transgenic animals |
08/07/2003 | WO2002050288A9 Neocentromere-based mini-chromosomes or artificial chromosomes |
08/07/2003 | WO2002046386A3 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
08/07/2003 | WO2002045659A9 Novel therapeutics for heart failure and aging |
08/07/2003 | WO2002033119A3 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
08/07/2003 | WO2002031121A9 Improvement of endothelial cell-cell cohesion |
08/07/2003 | WO2002020848A3 Gene and sequence variation associated with cancer |
08/07/2003 | WO2002018608A9 Methods for enhancing the efficacy of cancer therapy |
08/07/2003 | WO2002016625A3 Plant polynucleotides encoding prenyl proteases |
08/07/2003 | WO2002016559A3 In vivo animal model of human leukemia |
08/07/2003 | WO2002008381A3 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia |
08/07/2003 | WO2002002593A3 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
08/07/2003 | WO2001092578A3 Reagents and methods for identifying and modulating expression of genes regulated by retinoids |
08/07/2003 | US20030150013 Inducing plant somatic embryogenesis in absence of hormones using expression vector coding glucocorticoid and/or estrogen receptors and the regulatory proteins leafy cotyledon 1 (LEC1) and somatic embryogenesis receptor-like kinase (SERK) |
08/07/2003 | US20030150010 Comprises nucleotide sequences coding thioredoxin h protein for improving baking quality of cereal flour; neutralization of venomons; food processing |
08/07/2003 | US20030149999 Nonhuman animal model non-responsive to mycoplasma-origin lipoprotein/lipopeptide |
08/07/2003 | US20030149998 Nucleotide sequences coding orphan receptors/membrane proteins OM-10 and UP-11 for detecting modulators of inflammation, nervous system activity and infection; antitumor/antiinflammatory agents; gene expression inhibition |
08/07/2003 | US20030149996 Method for producing polyclonal and monoclonal antibodies |
08/07/2003 | US20030149256 Transferrin polynucleotides, polypeptides, and antibodies |
08/07/2003 | US20030149247 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
08/07/2003 | US20030149242 Novel polypeptide |
08/07/2003 | US20030149241 Nucleotide sequences coding osteogenic protein for induction/differentiation and/or treatment of bone, cartilage and other connective tissue defects; wound healing agents |